MP:0000063 | reduced bone density | "decreased mineral content of bone; indicator of bone strength" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:CLS, J:57315] |
Show
Allelic Composition: Atcayji/Atcayji Genetic Background: JIGR
|
MP:0000222 | decreased neutrophil count | "fewer than normal neutrophil numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0000223 | decreased monocyte count | "fewer than normal monocyte numbers" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0000921 | demyelination | "loss of the myelin sheath without loss of axons or fiber tracts" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0002169 | no phenotype detected | "normal, viable and fertile appearance and behavior; indistinguishable from controls" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pfkmtm1Fbos/Pfkmtm1Fbos Genetic Background: involves: 129S6/SvEvTac * C57BL/6J
|
MP:0002411 | decreased susceptibility to bacterial infection | "reduced likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Gt(ROSA)26Sortm3(NOTCH3*R1031C)Sat/Gt(ROSA)26Sor+,Tg(Tagln-cre)1Her/0 Genetic Background: involves: 129S2/SvEv * 129S6/SvEvTac * C57BL/6 * SJL
Allelic Composition: Ifnb1tm1Tl/Ifnb1tm1Tl Genetic Background: B6.129P2-Ifnb1tm1Tl
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Dclre1ctm1Fwa/Dclre1ctm1Fwa Genetic Background: involves: 129S6/SvEvTac
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
Allelic Composition: Ifnb1tm1Acgp/Ifnb1tm1Acgp Genetic Background: B6.129P2-Ifnb1tm1Acgp
|
MP:0003691 | abnormal microglial cell function | "anomalous activity of the small neuroglial cells, possibly of mesodermal origin, which may become phagocytic, in areas of neural damage or inflammation" [hdene:Howard Dene , Mouse Genome Informatics Curator] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0003721 | increased tumor growth/size | "greater than expected development of tumorous growth when compared to controls" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0003884 | decreased macrophage count | "fewer than the normal numbers of macrophages" [acv:Alicia Valenzuela, Genetic Resources Curator] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0004799 | increased susceptibility to experimental autoimmune encephalomyelitis | "greater likelihood that an organism will develop disease symptoms similar to human multiple sclerosis upon induction with antigens to Myelin Basic Protein (MBP), Proteolipid Protein (PLP), and/or Myelin Oligodendrocyte glycoprotein (MOG)" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0004982 | abnormal osteoclast morphology | "any structural anomaly of the bone resorpting cells that remove bone tissue by degrading the mineralized matrix" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Atcayji/Atcayji Genetic Background: JIGR
|
MP:0005025 | response to infection | "the body s reaction to invasion and multiplication of microorganisms in its tissues, or the body s reaction to components of or toxins produced by pathogenic mircroorganisms " [MeSH:National Library of Medicine - Medical Subject Headings , 2003, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Atcayji/Atcayji Genetic Background: JIGR
|
MP:0005348 | increased T cell proliferation | "increased clonal expansion of naive T cells in response to stimuli" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0006082 | CNS inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the brain and/or spinal cord" [smb:Susan M Bello, Mouse Genome Informatics Curator, ncbi:NCBI request] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0008208 | decreased pro-B cell number | "reduced number of the progenitor cells of the B cell lineage, with some lineage specific activity such as early stages of recombination of B cell receptor genes, but are not yet fully committed to the B cell lineage until the expression of PAX5 occurs" [CL:0000826, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0008211 | decreased mature B cell number | "reduced number of the mature form of B cells, a type of lymphocyte whose defining characteristic is the expression of an immunoglobulin complex" [CL:0000785, ISBN:0781735149] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0008471 | abnormal spleen primary B follicle morphology | "any structural anomaly of the nodules of small undifferentiated B lymphocytes and follicular dendritic cells located in the spleen white pulp" [PMID:17495967] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0008560 | increased tumor necrosis factor secretion | "increase in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0008561 | decreased tumor necrosis factor secretion | "reduction in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0008566 | increased interferon-gamma secretion | "increase in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0008574 | decreased circulating interferon-alpha level | "reduction in the amount in the blood of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Ifnb1tm2.1Lien/Ifnb1tm2.1Lien,Tyrc-2J/Tyrc-2J,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ifnb1tm1Tl/Ifnb1tm1Tl Genetic Background: B6.129P2-Ifnb1tm1Tl
|
MP:0008576 | decreased circulating interferon-beta level | "reduction in the amount in the blood of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Dclre1ctm1Fwa/Dclre1ctm1Fwa Genetic Background: involves: 129S6/SvEvTac
Allelic Composition: Ifnb1tm2.1Lien/Ifnb1tm2.1Lien,Tyrc-2J/Tyrc-2J,Lyz2tm1(cre)Ifo/Lyz2+ Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ifnb1tm1Tl/Ifnb1tm1Tl Genetic Background: B6.129P2-Ifnb1tm1Tl
|
MP:0008658 | decreased interleukin-1 beta secretion | "reduction in the production or release of an interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein on monocytes, macrophages and other cells; proteolytic processing of the precursor form by caspase 1 results in release of the active form of interleukin-1beta from the membrane" [MESH:D12.644.276.374.465.501.600] |
Show
Allelic Composition: Ifnb1tm1Acgp/Ifnb1tm1Acgp Genetic Background: B6.129P2-Ifnb1tm1Acgp
|
MP:0008699 | increased interleukin-4 secretion | "increase in the production or release of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: MipCat-Tohm/Mip+ Genetic Background: DDI
|
MP:0008813 | decreased common myeloid progenitor cell number | "reduced number of progenitor cells committed to myeloid lineage, including the megakaryocyte and erythroid lineages" [CL:0000049, MGI:llw2 "Linda Washburn, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|
MP:0008973 | decreased erythroid progenitor cell number | "reduced numbers of progenitors of the erythrocyte lineage" [CL:0000038, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Vav1tm1Tyb/Vav1tm1Tyb,Vav2tm1Tnr/Vav2tm1Tnr Genetic Background: involves: 129P2/OlaHsd * 129S2/SvPas
|